Quest Laboratories Limited (NSE:QUESTLAB)

Market Cap	1.64B
Revenue (ttm)	1.12B
Net Income (ttm)	161.93M
Shares Out	16.39M
EPS (ttm)	9.88
PE Ratio	10.11
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,400
Average Volume	71,700
Open	99.90
Previous Close	99.90
Day's Range	99.90 - 102.50
52-Week Range	75.15 - 160.00
Beta	n/a
RSI	52.30
Earnings Date	Aug 14, 2025

About Marinus Pharmaceuticals

Quest Laboratories Limited engages in the manufacture and sale of pharmaceutical formulations in India. It offers ethical drugs, generic drugs, and over the-counter drugs under various categories, such as antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and others. The company provides its products in various forms, such as tablets, liquid orals, oral dry powders, oral powders, ointments, external liquids, and oral suspension. It also engages in the cont...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 74
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: QUESTLAB

Financial Performance

In 2024, Quest Laboratories's revenue was 1.04 billion, an increase of 25.86% compared to the previous year's 825.63 million. Earnings were 135.65 million, an increase of 34.39%.